Retention time for corticosteroid-sparing systemic immunosuppressive agents in patients with inflammatory eye disease
about
Role of the retinal vascular endothelial cell in ocular diseaseMethotrexate for ocular inflammatory diseases.Long-term efficacy, tolerability and retention rate of azathioprine in 103 aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder patients: a multicentre retrospective observational study from the UK.Earlier immunomodulatory treatment is associated with better visual outcomes in a subset of patients with Vogt-Koyanagi-Harada disease.
P2860
Retention time for corticosteroid-sparing systemic immunosuppressive agents in patients with inflammatory eye disease
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Retention time for corticoster ...... with inflammatory eye disease
@ast
Retention time for corticoster ...... with inflammatory eye disease
@en
type
label
Retention time for corticoster ...... with inflammatory eye disease
@ast
Retention time for corticoster ...... with inflammatory eye disease
@en
prefLabel
Retention time for corticoster ...... with inflammatory eye disease
@ast
Retention time for corticoster ...... with inflammatory eye disease
@en
P2093
P2860
P356
P1476
Retention time for corticoster ...... with inflammatory eye disease
@en
P2093
A S Watkins
J T Rosenbaum
N J Spurrier
P2860
P304
P356
10.1136/BJO.2006.097998
P407
P577
2006-08-16T00:00:00Z